prostate SBRT

RADIATION2 trials

Sponsors

Royal Marsden NHS Foundation Trust, IRCCS San Raffaele

Conditions

Localized Prostate CarcinomaProstate Cancer

Phase 3

Prostate Advances in Comparative Evidence

Active, not recruitingNCT01584258

Royal Marsden NHS Foundation TrustProstate Cancer

Start: 2012-08-07End: 2027-12-31Updated: 2024-01-19

Unknown Phase

24 Gy in One Fraction Urethral-sparing HDR Like SBRT for Prostate Cancer

RecruitingNCT05936736

IRCCS San RaffaeleLocalized Prostate Carcinoma

Start: 2023-11-08End: 2030-05-31Target: 70Updated: 2025-06-08

Related Papers

Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRT.

2025-08-27

Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.

2025-06-125 citations

Prostate Brachytherapy With Cs-131

American Journal of Clinical Oncology2024-10-17

Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer

New England Journal of Medicine2024-10-16157 citations

PACE-A: An international phase 3 randomised controlled trial (RCT) comparing stereotactic body radiotherapy (SBRT) to surgery for localised prostate cancer (LPCa)—Primary endpoint analysis.

Journal of Clinical Oncology2023-02-2031 citations

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.

2022-09-13197 citations

Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts.

2019-09-2721 citations

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.

2019-09-17375 citations

PACE: Analysis of acute toxicity in PACE-B, an international phase III randomized controlled trial comparing stereotactic body radiotherapy (SBRT) to conventionally fractionated or moderately hypofractionated external beam radiotherapy (CFMHRT) for localized prostate cancer (LPCa).

Journal of Clinical Oncology2019-03-0129 citations

Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI.

2019-02-1228 citations

The PACE trial: International randomised study of laparoscopic prostatectomy vs. stereotactic body radiotherapy (SBRT) and standard radiotherapy vs. SBRT for early stage organ-confined prostate cancer.

Journal of Clinical Oncology2018-02-2015 citations